-
A new era in migraine treatment: Innovative drugs redefining the field
13 Jun 2025 19:07 GMT
… anti-nausea medications, antidepressants, anti-seizure drugs, and … biotech industry has come up with novel migraine treatments … , in clinical trials, they were shown … treatment of meloxicam and rizatriptan – meloxicam is a nonsteroidal anti-inflammatory drug …
-
US FDA approves Azurity Pharma's Xifyrm for management of moderate─to─severe pain in adults
12 Jun 2025 07:04 GMT
… medicines, announced that the US Food and Drug Administration (FDA) has approved Xifyrm (meloxicam … Ron Scarboro, CEO at Azurity Pharmaceuticals. “Xifyrm addresses an important clinical … in the coming weeks.
Azurity Pharmaceuticals is a privately held company …
-
Axsome Therapeutics introduces Symbravo in US for acute treatment of migraine with or without aura in adults
11 Jun 2025 10:39 GMT
… treatment of central nervous system (CNS) disorders, announced that Symbravo (meloxicam … new FDA-approved option for the acute treatment of … this important and distinct medicine, we are also … Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory drug …
-
FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults
10 Jun 2025 18:50 GMT
Meloxicam injection (Xifyrm; Azurity Pharmaceuticals, Inc) received FDA approval for use in adults … with non-steroidal anti-inflammatory drug (NSAID) analgesics. The approval … also aligns with FDA and Centers for Medicare & Medicaid Services (CMS) …
-
Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
10 Jun 2025 11:00 GMT
… treatment of central nervous system (CNS) disorders, today announced that SYMBRAVO® (meloxicam … antidepressant medicines called SSRIs or SNRIs. Stop taking SYMBRAVO and call your doctor … drugs to the FDA. Visit www.fda. … trials and anticipated clinical trials …
-
Viatris Korea moves beyond off-patent drugs under Schuster’s leadership, eyes new drug launches
10 Jun 2025 08:01 GMT
… local partners like Jeil Pharmaceutical and SK chemicals.
A … 02, a rapid-acting meloxicam formulation that recently showed … in phase 3 trials, with FDA submission planned for … treatment for generalized anxiety disorder, addressing a significant unmet medical …
-
People’s Pharmacy: Why didn’t my doctor warn me about this effect on my blood pressure?
27 May 2025 15:43 GMT
… could think of was the meloxicam. It was working very … attack.
A. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) like … indeed too high! Your doctor should have mentioned this potential … information on a variety of medications used to lower blood …
-
FDA Approves Chinese Non-Opioid Painkiller Alternative To Morphine That Could Reduce Fentanyl Overdoses
27 May 2025 08:59 GMT
… by Nanjing-based biotech firm Delova, Qamzova … treatment,” said a Shanghai anesthetist.
Li Jianhua, a drug … contains meloxicam, a non-steroidal anti-inflammatory drug (NSAID … medical needs” in pain care, Qamzova also highlights China’s growing pharmaceutical …
-
US: FDA greenlights China's 1st painkiller to combat fentanyl overdoses"
25 May 2025 10:40 GMT
… non-steroidal anti-inflammatory (NSAID) drugs, much like popular painkillers such … meloxicam, a component commonly used to alleviate inflammation and pain.
Clinical trials …
-
Ferroptosis: New Strategies for Clinical Treatment of Rheumatoid Arthritis
21 May 2025 11:46 GMT
… drugs targeting ferroptosis in RA, and combined traditional Chinese medicine diagnosis and treatment … RA showed that diclofenac, meloxicam, and celecoxib exhibit varying … of action of traditional Chinese medicine treatment is complex, lacking standardization …